The benefits and costs of tamoxifen for breast cancer prevention

• Główni autorzy: Simon D. Eckermann (Autor), Andrew J. Martin (Autor), Martin R. Stockier (Autor), R. John Simes (Autor)
• Format: Książka
• Wydane: Elsevier, 2003-02-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Abstract Objective: To estimate the effects of key uncertainties on the effectiveness and cost‐effectiveness of breast cancer prevention with tamoxifen. Methods: The incremental cost‐effectiveness ratio of tamoxifen therapy relative to placebo was estimated using decision analysis with Markov modell...